(0.81%) 5 059.00 points
(0.76%) 38 192 points
(1.35%) 15 816 points
(0.06%) $79.05
(5.02%) $2.03
(0.28%) $2 317.40
(0.62%) $26.91
(1.08%) $965.25
(-0.05%) $0.933
(-0.38%) $10.99
(-0.04%) $0.798
(-1.36%) $91.99
Quarter results today
(bmo 2024-05-02)
Expected move: +/- 4.97%
Live Chart Being Loaded With Signals
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide...
Stats | |
---|---|
Šios dienos apimtis | 283 603 |
Vidutinė apimtis | 295 921 |
Rinkos kapitalizacija | 9.38B |
EPS | $0 ( 2024-02-22 ) |
Kita pelno data | ( $0 ) 2024-08-01 |
Last Dividend | $0.340 ( 2023-11-14 ) |
Next Dividend | $0 ( N/A ) |
P/E | 26.41 |
ATR14 | $0.159 (0.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-02 | Deren John | Sell | 137 | Common Stock |
2024-03-05 | Hicks Cameron P | Buy | 4 400 | Common Stock |
2024-03-05 | Hicks Cameron P | Buy | 3 001 | Common Stock |
2024-03-05 | Hicks Cameron P | Sell | 7 401 | Common Stock |
2024-03-02 | Hicks Cameron P | Sell | 216 | Common Stock |
INSIDER POWER |
---|
36.97 |
Last 98 transactions |
Buy: 315 370 | Sell: 125 241 |
Tūris Koreliacija
Teleflex Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Teleflex Inc Koreliacija - Valiuta/Žaliavos
Teleflex Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $2.97B |
Bruto pelnas: | $1.65B (55.37 %) |
EPS: | $7.58 |
FY | 2023 |
Pajamos: | $2.97B |
Bruto pelnas: | $1.65B (55.37 %) |
EPS: | $7.58 |
FY | 2022 |
Pajamos: | $2.79B |
Bruto pelnas: | $1.53B (54.86 %) |
EPS: | $7.74 |
FY | 2021 |
Pajamos: | $2.81B |
Bruto pelnas: | $1.55B (55.15 %) |
EPS: | $10.38 |
Financial Reports:
No articles found.
Teleflex Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.340 (N/A) |
$0.340 (N/A) |
$0.340 (N/A) |
$0.340 (N/A) |
$0.680 (N/A) |
$0.340 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0283 | 1987-05-19 |
Last Dividend | $0.340 | 2023-11-14 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-15 | |
Next Payout Date | N/A | |
# dividends | 148 | -- |
Total Paid Out | $32.39 | -- |
Avg. Dividend % Per Year | 0.33% | -- |
Score | 5.32 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.52 | |
Div. Directional Score | 8.97 | -- |
Year | Amount | Yield |
---|---|---|
1987 | $0.0849 | 1.03% |
1988 | $0.127 | 1.65% |
1989 | $0.153 | 1.56% |
1990 | $0.175 | 1.69% |
1991 | $0.195 | 1.80% |
1992 | $0.208 | 1.24% |
1993 | $0.225 | 1.42% |
1994 | $0.260 | 1.42% |
1995 | $0.300 | 1.72% |
1996 | $0.340 | 1.64% |
1997 | $0.388 | 1.52% |
1998 | $0.445 | 1.20% |
1999 | $0.505 | 1.14% |
2000 | $0.580 | 1.86% |
2001 | $0.660 | 1.58% |
2002 | $0.710 | 1.53% |
2003 | $0.780 | 1.76% |
2004 | $0.860 | 1.79% |
2005 | $0.970 | 1.91% |
2006 | $1.105 | 1.68% |
2007 | $1.245 | 1.89% |
2008 | $1.340 | 2.12% |
2009 | $1.360 | 2.69% |
2010 | $1.360 | 2.45% |
2011 | $1.360 | 2.51% |
2012 | $1.360 | 2.21% |
2013 | $1.360 | 1.88% |
2014 | $1.360 | 1.47% |
2015 | $1.360 | 1.19% |
2016 | $1.360 | 1.06% |
2017 | $1.360 | 0.86% |
2018 | $1.360 | 0.53% |
2019 | $1.360 | 0.54% |
2020 | $1.360 | 0.36% |
2021 | $1.360 | 0.34% |
2022 | $1.360 | 0.41% |
2023 | $1.700 | 0.68% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
ZTR | Dividend Royal | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.120 | 1.500 | 7.60 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0473 | 1.200 | 8.42 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0834 | 1.500 | -0.184 | -0.276 | [0.1 - 1] |
payoutRatioTTM | 0.179 | -1.000 | 8.21 | -8.21 | [0 - 1] |
currentRatioTTM | 2.32 | 0.800 | 3.40 | 2.72 | [1 - 3] |
quickRatioTTM | 1.126 | 0.800 | 8.08 | 6.47 | [0.8 - 2.5] |
cashRatioTTM | 0.367 | 1.500 | 9.07 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.256 | -1.500 | 5.74 | -8.61 | [0 - 0.6] |
interestCoverageTTM | 5.63 | 1.000 | 9.03 | 9.03 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.86 | 2.00 | 6.38 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 8.92 | 2.00 | 5.54 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.434 | -1.500 | 8.26 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.554 | 1.000 | 4.11 | 4.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.161 | 1.000 | 8.78 | 8.78 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.265 | 1.000 | 9.64 | 9.64 | [0.2 - 2] |
assetTurnoverTTM | 0.395 | 0.800 | -0.701 | -0.561 | [0.5 - 2] |
Total Score | 11.42 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 27.90 | 1.000 | 7.28 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0834 | 2.50 | -0.118 | -0.276 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 8.92 | 2.00 | 7.03 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.643 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.86 | 2.00 | 6.38 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.179 | 1.500 | 8.21 | -8.21 | [0 - 1] |
pegRatioTTM | 0.946 | 1.500 | 7.03 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.172 | 1.000 | 8.21 | 0 | [0.1 - 0.5] |
Total Score | 6.52 |
Teleflex Inc
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.